Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life CyclePaola Favuzza, Alan F. Cowman, Marissa Vavrek et al.|Cell Host & Microbe|2020Cited by 167
The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of MalariaManuel de Lera Ruiz, John A. McCauley, Paola Favuzza et al.|ACS Medicinal Chemistry Letters|2022Cited by 26
MK-7602: a potent multi-stage dual-targeting antimalarialPaola Favuzza, Alan F. Cowman, Josephine Palandri et al.|EBioMedicine|2025Cited by 6